Insider trades
Sanjay Chanda, Chief Officer of AN2 Therapeutics ANTX, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $9,311. The latest trade was on 03/19.
Sanjay Chanda
Chief Development Officer
- Company
- AN2 Therapeutics ANTX
- First filing
- 23/02/17
- Trades
- 17 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- −$9,311
- Last trade
- 03/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANTX | Open-market sale | 01/05–01/06 | 01/07 | 9,251 sh2 trades | $1.01avg. | $9,310.56 | −10.9% |
AN2 TherapeuticsANTX | Open-market sale | 25/01/03 | 25/01/07 | 2,957 sh | $1.34 | $3,962.38 | −9.0% |